These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 1605652)
1. [Chemotherapy of advanced breast cancer]. Ogawa M Gan To Kagaku Ryoho; 1992 Jun; 19(6):769-74. PubMed ID: 1605652 [TBL] [Abstract][Full Text] [Related]
2. [Treatment strategy to obtain cure for recurrent advanced breast cancer]. Ogawa M; Mukaiyama T Gan To Kagaku Ryoho; 1994 Jun; 21 Suppl 2():259-63. PubMed ID: 7518661 [TBL] [Abstract][Full Text] [Related]
3. [CMF or CAF combination chemotherapy for breast cancer]. Ota J Gan To Kagaku Ryoho; 1996 Dec; 23(14):1886-90. PubMed ID: 8978791 [TBL] [Abstract][Full Text] [Related]
4. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial. Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J; J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969 [TBL] [Abstract][Full Text] [Related]
5. [Significance of cytostatic drug dose in adjuvant chemotherapy of breast carcinoma]. Thomssen C Geburtshilfe Frauenheilkd; 1996 Jul; 56(7):M102-5. PubMed ID: 8964443 [No Abstract] [Full Text] [Related]
6. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease. de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878 [TBL] [Abstract][Full Text] [Related]
7. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial. Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712 [TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) on advanced and recurrent breast cancer. Clinical study group of CMF for breast cancer in Japan]. Nomura Y; Tominaga T; Adachi I; Koyama H; Fukami A Gan To Kagaku Ryoho; 1994 Sep; 21(12):1949-56. PubMed ID: 8085846 [TBL] [Abstract][Full Text] [Related]
9. High-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer: a 10-year experience. Laport GF; Grad G; Grinblatt DL; Bitran JD; Williams SF Bone Marrow Transplant; 1998 Jan; 21(2):127-32. PubMed ID: 9489628 [TBL] [Abstract][Full Text] [Related]
10. [Evolution of adjuvant chemotherapy of breast cancer from Bonadonna to the taxanes]. Nagykálnai T Magy Onkol; 2002; 46(4):307-13. PubMed ID: 12563352 [TBL] [Abstract][Full Text] [Related]
11. Sequential adjuvant therapy: the Memorial Sloan-Kettering Cancer Center experience. Hudis C; Seidman A; Raptis G; Fennelly D; Gilewski T; Baselga J; Theodoulou M; Sklarin N; Moynahan M; Surbone A; Currie V; Lebwohl D; Uhlenhopp M; Crown J; Norton L Semin Oncol; 1996 Feb; 23(1 Suppl 1):58-64. PubMed ID: 8629040 [TBL] [Abstract][Full Text] [Related]
12. Modulation of molecular marker expression by induction chemotherapy in locally advanced breast cancer: correlation with the response to therapy and the expression of MDR1 and LRP. Schneider J; Lucas R; Sánchez J; Ruibal A; Tejerina A; Martín M Anticancer Res; 2000; 20(6B):4373-7. PubMed ID: 11205274 [TBL] [Abstract][Full Text] [Related]
13. Phase III study of standard combination versus rotating regimen of induction chemotherapy in patients with hormone insensitive metastatic breast cancer: an Eastern Cooperative Oncology Group Intergroup Study (E3185). Pandya KJ; Hu P; Osborne CK; Falkson G; Tormey DC; Am J Clin Oncol; 2007 Apr; 30(2):113-25. PubMed ID: 17414459 [TBL] [Abstract][Full Text] [Related]
14. Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897. Ganz PA; Hussey MA; Moinpour CM; Unger JM; Hutchins LF; Dakhil SR; Giguere JK; Goodwin JW; Martino S; Albain KS J Clin Oncol; 2008 Mar; 26(8):1223-30. PubMed ID: 18227530 [TBL] [Abstract][Full Text] [Related]
15. [Adriamycin--breast cancer]. Nomura Y Gan To Kagaku Ryoho; 1996 Dec; 23(14):1911-5. PubMed ID: 8978796 [TBL] [Abstract][Full Text] [Related]
16. [A study of complete responders in cases of metastatic breast cancer treated with combination chemotherapy]. Shinagawa K; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Fukutani H; Tabata M; Hirano A; Mizunuma N Gan No Rinsho; 1989 Apr; 35(5):581-6. PubMed ID: 2541272 [TBL] [Abstract][Full Text] [Related]
17. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer. Klaassen U; Wilke H; Seeber S Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897 [TBL] [Abstract][Full Text] [Related]
18. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer. Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034 [TBL] [Abstract][Full Text] [Related]
19. Poor outcome of patients with resectable breast cancer receiving adjuvant high-dose sequential chemotherapy following preoperative treatment. Zambelli A; Da Prada GA; Pedrazzoli P; Ponchio L; Robustelli della Cuna G Anticancer Res; 1999; 19(3B):2373-6. PubMed ID: 10472359 [TBL] [Abstract][Full Text] [Related]
20. Pilot study of primary chemotherapy with doxorubicin plus paclitaxel in women with locally advanced or operable breast cancer. Moliterni A; Tarenzi E; Capri G; Terenziani M; Bertuzzi A; Grasselli G; Agresti R; Piotti P; Greco M; Salvadori B; Pilotti S; Lombardi F; Valagussa P; Bonadonna G; Gianni L Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-10-S17-14. PubMed ID: 9374085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]